本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Arcutis Biotherapeutics Inc.

17.29
-0.4000-2.26%
盘后17.450.1550+0.90%19:31 EDT
成交量:140.70万
成交额:2,429.96万
市值:20.73亿
市盈率:-23.28
高:17.71
开:17.63
低:16.92
收:17.69
52周最高:18.15
52周最低:8.03
股本:1.20亿
流通股本:8,558.07万
量比:0.64
换手率:1.64%
股息:- -
股息率:- -
每股收益(TTM):-0.7427
每股收益(LYR):-1.1578
净资产收益率:-57.33%
总资产收益率:-13.46%
市净率:14.92
市盈率(LYR):-14.93

数据加载中...

2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/11/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/14

重要事件披露

Form 8-K - Current report
2024/08/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities